CN1173648C - Composite casein polypeptide beverage - Google Patents
Composite casein polypeptide beverage Download PDFInfo
- Publication number
- CN1173648C CN1173648C CNB011152435A CN01115243A CN1173648C CN 1173648 C CN1173648 C CN 1173648C CN B011152435 A CNB011152435 A CN B011152435A CN 01115243 A CN01115243 A CN 01115243A CN 1173648 C CN1173648 C CN 1173648C
- Authority
- CN
- China
- Prior art keywords
- beverage
- polypeptide
- peptide
- casein
- composite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Non-Alcoholic Beverages (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to a composite casein polypeptide beverage which is a polypeptide beverage made by adding compound casein polypeptide in the working procedure of preparing various well-known beverages during the batching. In the present invention, the compound casein polypeptide is added in the beverage, so the beverage has the bioactivity action of the compound casein polypeptide and is conveniently and widely drunk by people.
Description
The present invention relates to a kind of beverage that contains the casein polypeptide.
Polypeptide is a kind of bioactivator, can directly be absorbed by human body, and different peptides has different physiological functions.The peptide that studies have shown that in the cow's milk peptide has: the blood pressure lowering peptide that suppresses angiotensin I invertase activity; The morphine-like peptide that tranquilizing soporific is arranged; The immunomodulatory peptides that can suppress bacterium and virus infections; Suppress hematoblastic cohesion and fibrinogen and be attached to antithrombotic peptide on the blood platelet that ADP activates; Promote the CPP that calcium, iron, zinc absorb; Promote the peptide that DNA is synthetic and cell is grown: antibiotic anticancer anti-mutagenized polypeptide etc.
At present, external active casein polypeptide played a part with different effects in fields such as health products, medicine, beverage additive, family's non-staple food special.Casein is degraded to the focus that active peptides is present dairy products research and development with various enzymes.Abroad, the part casein peptide is commercialization and very fast-selling, aspect this biotechnology, at present Japan and Northern Europe are walked in prostatitis, secondly countries such as the U.S., Australia, Germany, France, Korea S all carry out positive research, and in the end of the year 1989, Japan has at first realized CPP suitability for industrialized production, release the functional food that contains active peptides simultaneously, Denmark also realized commercialization in 1991.Functional food comes from Japan, and is also in vogue in Japan at present.Japan has been applied to polypeptide the beverage that children's curry meal, liquid nutritional food, candy, strong bone are replenished the calcium, allergic reaction dairy produce for baby " MA-1 ", " MA-2 " etc.Taiwan also has the CPP beverage that all contains of commodity " the good iron of calcium " by name to go on the market, and the utmost point gets consumer reception.France successfully is that the antithrombotic peptide of raw material behind enzymolysis made the product that prevents and treat thrombotic disease with CMP in the nineties.
The chemical elementary cell of active casein polypeptide is an amino acid, constitutes the different peptides with given efficacy because of amino acid whose composition is different.Product appearance is white or light yellow powdery, has unique bitter taste when debitterize is not distinguished the flavor of, and is soluble in water, because its very high nutritive value and specific physiological function are widely used in fields such as grocery trade, health products, medicine, feed, family's non-staple food.In recent years, studies have shown that both at home and abroad that small-molecular peptides has higher biologically active and nutritive value than the free amino acid of equivalent, and polypeptide is almost all directly absorbed in human body.
The objective of the invention is composite casein polypeptide to be added in the beverage in order to provide a kind of, make beverage have composite casein polypeptide biological action, be convenient to the popular composite casein polypeptide beverage of extensively drinking.
Purpose of the present invention can realize by following measure:
A kind of composite casein polypeptide beverage is in the preparation section of known various types of beverages, when it is prepared burden, composite casein polypeptide is added, and wherein composite casein polypeptide is the 0.5-2% of beverage weight.At least two kinds of peptides that described composite casein polypeptide is selected from casein phosphopeptide, calcium peptide, blood pressure lowering peptide, antithrombotic peptide, morphine peptide, immunomodulatory peptides, the anti-mutagenized polypeptide mix the formation complex polypeptide.
The present invention has following advantage compared to existing technology:
1, the present invention is compounded into the composite casein polypeptide of tool bioactivator in the beverage, makes the biologically active that also has composite casein polypeptide in the beverage except that the trophism of himself; Simultaneously some disease is also had special dietary function, make it meet the theory of the integration of drinking and medicinal herbs on the theory of traditional Chinese medical science.
2, the present invention can play human body and regulate immunity of organisms, delay senility, anti-mutagenesis, prevent effect such as osteoporosis.
The present invention also will be described in further detail in conjunction with the embodiments:
Embodiment one:
A kind of composite casein polypeptide beverage is in the preparation section of known carbonated beverage, adds casein phosphopeptide, calcium peptide when it is prepared burden, and wherein casein phosphopeptide is 0.2% of a beverage weight, and CCP is 0.1% of a beverage weight; Casein phosphopeptide, calcium peptide and beverage be mixed get final product.
Embodiment two:
A kind of composite casein polypeptide beverage is in known protide beverage preparation operation, when batching, add casein phosphopeptide, calcium peptide, blood pressure lowering peptide, antithrombotic peptide, wherein casein phosphopeptide is 0.1% of a beverage weight, CCP is 0.2% of a beverage weight, blood pressure lowering peptide is 1% of a beverage weight, and the antithrombotic peptide is 0.5% of a beverage weight; Casein phosphopeptide, calcium peptide, blood pressure lowering peptide, antithrombotic peptide and beverage be mixed get final product.
Embodiment three:
A kind of composite casein polypeptide is in known fruit drink preparation section, when batching, add casein phosphopeptide, calcium peptide, blood pressure lowering peptide, antithrombotic peptide, morphine peptide, immunomodulatory peptides, anti-mutagenized polypeptide, wherein casein phosphopeptide is 0.1% of a beverage weight, CCP is 0.1% of a beverage weight, blood pressure lowering peptide is 0.1% of a beverage weight, the antithrombotic peptide is 0.3% of a beverage weight, the morphine peptide is 0.3% of a beverage weight, immunomodulatory peptides is 0.1% of a beverage weight, and anti-mutagenized polypeptide is 0.1% of a beverage weight; Casein phosphopeptide, calcium peptide, blood pressure lowering peptide, antithrombotic peptide, morphine peptide, immunomodulatory peptides, anti-mutagenized polypeptide and beverage be mixed get final product.
Claims (1)
1, a kind of composite casein polypeptide beverage is characterized in that in the preparation section of known various types of beverages, when it is prepared burden, composite casein polypeptide is added, and wherein composite casein polypeptide is the 0.5-2% of beverage weight; At least two kinds of peptides that described composite casein polypeptide is selected from casein phosphopeptide, calcium peptide, blood pressure lowering peptide, antithrombotic peptide, morphine peptide, immunomodulatory peptides, the anti-mutagenized polypeptide mix the formation complex polypeptide.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011152435A CN1173648C (en) | 2001-04-27 | 2001-04-27 | Composite casein polypeptide beverage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011152435A CN1173648C (en) | 2001-04-27 | 2001-04-27 | Composite casein polypeptide beverage |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1383761A CN1383761A (en) | 2002-12-11 |
| CN1173648C true CN1173648C (en) | 2004-11-03 |
Family
ID=4661820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011152435A Expired - Fee Related CN1173648C (en) | 2001-04-27 | 2001-04-27 | Composite casein polypeptide beverage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1173648C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105124695A (en) * | 2015-08-26 | 2015-12-09 | 黑龙江省科学院火山与矿泉研究所 | Infant drinking water capable of promoting calcium absorption and preparation method thereof |
| CN105130053A (en) * | 2015-08-31 | 2015-12-09 | 黑龙江省科学院火山与矿泉研究所 | Infant drinking water for promoting iron absorption and preparation method thereof |
| CN108077696A (en) * | 2018-01-10 | 2018-05-29 | 广东日可威食品原料有限公司 | A kind of thyme sports drink for recovering teenager's physical efficiency |
| CN108378258A (en) * | 2018-02-09 | 2018-08-10 | 李冠楠 | A kind of American ginseng beverage and preparation method thereof |
-
2001
- 2001-04-27 CN CNB011152435A patent/CN1173648C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1383761A (en) | 2002-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101518295B (en) | Method for preparing powder rich in whey small peptides with molecular weight of 1000 daltons | |
| OA12703A (en) | Stable and bioavailable iron fortified beverages. | |
| CN1650731A (en) | Corn peptide beverage and its processing method | |
| WO2015194205A1 (en) | Cyclic dipeptide-containing composition | |
| CN101214051A (en) | Donkey-hide gelatin jujube beverage and preparation thereof | |
| CN101341908A (en) | High-protein milk | |
| CN1141394C (en) | Production process of active casein polypeptide with coarse cheese | |
| CN1173648C (en) | Composite casein polypeptide beverage | |
| CN1679628A (en) | Yak myeloid calcium tablets | |
| CN101548769B (en) | Ginger cola health drink and preparation technology thereof | |
| CN1173633C (en) | Polypeptide biscuit | |
| CN1173632C (en) | Nutritious health polypeptide flour | |
| CN102986884A (en) | Sweet-scented osmanthus milk tea and making method thereof | |
| CN1199573C (en) | Polypeptide fortified milk | |
| CN1164191C (en) | Polypeptide chewing gum | |
| CN106616152A (en) | Manufacturing method of tremella fermented solid beverage | |
| CN1049005C (en) | Beermate and preparation method thereof | |
| CN1294831C (en) | Ice cream soymilk powder | |
| JPH02154673A (en) | Production of beverage containing water-soluble dietary fiber | |
| CN101283705A (en) | Milk powder containing peptide constituents and its preparation method | |
| JP5496743B2 (en) | Beverage composition | |
| CN1383737A (en) | Polypeptide bean curd | |
| CN103120212A (en) | Fortified milk | |
| CN1489934A (en) | Soya bean beverage | |
| CN1383745A (en) | Casein and composite polypeptide casein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041103 Termination date: 20100427 |